Status:
UNKNOWN
Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic Cancer
Lead Sponsor:
Fudan University
Conditions:
Pancreatic Cancer
Surgery
Eligibility:
All Genders
19-80 years
Phase:
NA
Brief Summary
Open distal pancreatectomy (ODP) has been commonly employed for the treatment of a variety of cancers in body and tail of pancreas. Although many general surgical procedures have been increasingly per...
Eligibility Criteria
Inclusion
- Age ≥ 19 years and ≤ 80 years, no gender limitation
- Resectable body and tail pancreatic cancer (refer to NCCN 2018)
- Eastern Cooperative Oncology Group (ECOG) performance status 0-1
- Tumor locates at the body and tail of the pancreas without distant metastasis
- No celiac trunk and superior mesenteric artery invasion
- No operation contraindication, fit for laparoscopic surgery
- The expected survival after surgery ≥ 3 months
- Patients who are willing and able to comply with the study procedure
- Signed informed content obtained prior to treatment
Exclusion
- Locally advanced unresectable body and tail pancreatic cancer
- Multi-organ and vascular resection needed
- Patients undergoing total pancreatectomy
- Benign tumor at the body and tail of the pancreas or pancreatic cancer at the head of the pancreas
- Distant metastasis or ascites detected by imaging
- Severe important organ function impairment (heart, liver, kidney)
- Patients who are with other primary malignancy or haematological disorders
- Pregnant or nursing women
- Patients who have received chemotherapy, radiotherapy and interventional therapy before the pancreatectomy
- Patients who have participated in other clinical trials for pancreatic cancer treatment within 3 months
Key Trial Info
Start Date :
February 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2023
Estimated Enrollment :
306 Patients enrolled
Trial Details
Trial ID
NCT03792932
Start Date
February 2 2019
End Date
January 31 2023
Last Update
June 22 2022
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Hefei, Anhui, China
2
Department of Hepatobiliary and Pancreatic Surgery, The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
3
Department of Hepatopancreatobiliary Surgery, Second Affiliated Hospital of Harbin Medical University,
Harbin, Heilongjiang, China
4
Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China